Pod Insights Pharmacy Podcast Network Balancing Patient Care with Financial Strategy: Navigating Pharmacy Reimbursement | Cardinal Health™ Counter Talk™ Podcast About this episode From reimbursements to inventory management, independent pharmacists face ongoing pressure to optimize the financial health of their business. In this episode, Jean Paul Gibeault, PharmD, RPh of Atlantic Health System shares how their two retail pharmacies have maintained strong financial performance using solutions like Cardinal Health™ Reimbursement Consulting Services (RCS). He discusses how real-time intelligence and a robust analytics and consulting platform can transform a pharmacy’s bottom line. Listen to uncover financial strategies that can help boost revenue and expand patient reach while upholding an unwavering commitment to quality, community care.
Transcript 0:05 Speaker 00 You are listening to the global network of podcasters dedicated to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
0:22 Speaker 01 The testimonials appearing in this podcast reflect individual experiences and individual results may vary. Cardinal Health does not claim, nor should the listener assume, that any individual experience recounted in this podcast is representative of what another consumer may experience.
0:41 Speaker 01 The Cardinal Health Counter Talk Podcast in collaboration with Pharmacy Podcast Network is for independent pharmacists to learn about the state of the industry, innovative services and solutions, and the future of pharmacy. Join me, your host, Jason Calori, for conversations with pharmacists, Cardinal Health leaders and industry experts, sharing best practices, discussing industry trends, and showcasing Cardinal Health products and services. You can subscribe to the Cardinal Health Counter Talk Podcast on Spotify, Apple Podcasts, and wherever you listen to your favorite podcasts.
1:10 Speaker 02 Hello, everyone, and welcome back to the Cardinal Health Counter Talk Podcast. I am your host, Jason Calori, and today is an episode that I'm sure is on everyone's mind these days, and on improving your retail-independent pharmacy's financial health. So today, we'll be talking with 17-year pharmacist Jean-Paul Jubot from Morristown Medical Center in Morristown, New Jersey, and part of the Atlantic Health System. He has implemented and supported both programs and contracts resulting in new realized multimillion-dollar fiscal revenue increases and internal savings across the pharmacies, reaching more patients every year, as well as helping thousands of AHS patients access medicine at lower costs through multiple programs and patient access initiatives. Welcome to the show, Jean.
1:56 Speaker 03 Thanks, Jason. Thanks, everyone, for having me here. It's a great, great experience and I'm hoping to share my experiences with the team and other pharmacies as well.
2:05 Speaker 02 Yeah, so not to follow too much of a script here, but I do want to ask you, like I do every guest that comes on, what was your journey into the pharmacy profession?
2:14 Speaker 03 Great. Like you mentioned, I'm a pharmacist of 17 years, a farm D. I remember way back in the days of those early pre-college, pre-med courses, working as a pharmacy technician, just kind of to get by and things like that on the day-to-day. Someone I respect that I work with is a really hardworking individual who really went out of his way and kind of included me, kind of leaned over to me and said, "Hey, if I can do this, you can do this, kid. You should sign up with school. You know, I think you've got some potential." And not immediately, it's something that happened over many years, but the long kind of transition through six years of pharmacy school, financing, largely myself with some federal funds and kind of really learning to achieving and get into to become a pharmacist, acting and licensed was quite a process. It really, it changed me for
2:57 Speaker 03 the better and really, really helped me see different parts of the world. Then my earlier farm D post-years across retail and specialty community settings throughout New Jersey, and I've managed it independently for years while providing population-specific services like immunizations, pre-COVID, during COVID, helped provide and introduce meds to beds at Overlook Medical Center in Summit, New Jersey, and other quality initiatives across Atlantic since coming on board in 2021 with our teams here. Today, I've managed the business, financial, and patient access features of our three outpatient pharmacies at Atlantic. I serve as our official NCPDP contact. And since 2021, I think in your intro, mentioned it pretty, pretty good, each year, we've implemented
3:40 Speaker 03 and supported new programs and contracts onboard every single year, resulting in new revenue, new increases in internal savings, and also, the best part is reaching more patients every year. 24 and change percent actually for this past year, which is a huge increase for us as a system, and our community as well. So happy to share our secrets, what our difficulties are and are the challenges of independent pharmacy.
4:08 Speaker 02 Yeah, so you're a little bit of a jack of all trades. You've kind of touched on a lot of different aspects of pharmacy in your career, which is always good as you go forward and implementing these new services as you've discussed. Why did Atlantic Health System choose to open a retail pharmacy with Morristown Medical Center and also Newton Medical Center? And also, if you could explain a little bit, maybe dive a little deeper into what the Atlantic Health System, what their job is, what they are, their entity, and why they are deciding to open some pharmacies and what that network looks like?
4:42 Speaker 03 Beautiful. Yeah, absolutely. Atlantic Health is a regional player and it's so great to be a part of this team. I was actually selected out of a different pharmacy role to come on board with our business financial contracts and quality. And it's really developed over the years since 2021. But to give you the background, so as far as outpatient pharmacies at our system, across our system, first outpatient pharmacy was launched in 2009. It's a closed-door pharmacy. It's based out of Livingston. It's up and running and growing, providing core pharmacy services to our team members at a net value for our system. We've since that time and over the years, we've scaled that net value savings by multiple things, including avoiding dispensing fees, combined with preferred product invoice purchases
5:25 Speaker 03 with Cardinal, tracking rebate opportunities, direct and indirect, that quickly brought the value to the system. It became very clear that we had a positive impact as part of the system. Our two retail units followed in 2013. Basically, across our system at that time, if we're going back a little bit here, there's a lot of buzz of meds to beds. There's a lot of buzz of quality. The independent outpatient, we're seeing huge losses and challenges, which we still do see. But kind of everyone's asking where to go, where's that value? Is it through Part D, tracking patients, adherence? And the buzz in our system, like a lot of others, was can we open a retail that supports direct adherence goals, allows for meds to beds,
6:09 Speaker 03 provides transitions teams with insights into the challenges even for our patients who don't fill with our pharmacies, but based on our inside knowledge? And following that buzz, First, our first opening was MMC Retail, which is our current largest format one at Morristown Medical Center in Morristown, New Jersey, 2013. Serves our whole health system, community staff, Newton, subsequently a little bit west, and our system represents that region and also helps patients from all walks of life. The next year, they got their NPI up and running. We kind of, there was this buzz and there was financial support behind that one but two extensions. So we went with that. And since launch, they've been open and have developed their internal
6:51 Speaker 03 and external kind of patient sets through the years. We've, both sites have meds to beds. At Morristown, we're servicing more than 10 grant-based, need-based programs. I effectuated some of the financials on that as well as work to make sure we have continuous flows matching the right populations. And we also meet with different, outside of pharmacy, those with stakeholders in patient care. It could be members of grants, it could be the medical groups, it could be practices who aren't able to access medication. So it's kind of developed into a really excellent footprint at both facilities with an appetite for more in the future, as long as we're able to keep our net positive margins on the volatile retail side, as we know, and independent pharmacy.
7:31 Speaker 02 Yeah, well, I mean, let's talk about that a little bit. I actually want to know, I want you to dive a little bit deeper into not only the services that you have, that your retail pharmacies provide, but also the population you serve. Tell us a little bit about that.
7:43 Speaker 03 So the patient populations are, I would say, very significantly. And our goal is to treat all the patients. So I would say our core population base that we treat that is on the financial kind of structural side is actually our team members. So at both of our outpatient pharmacies at Morristown and Newton, maybe not 50%, the ratio varies, but this last year, we had a record number of fills across all of our pharmacies by our team members, greater than one in four of those who didn't have to use our services, who work for us, you know, they get a better copay, opted to use our pharmacies. So greater than 25% of our entire system, greater than 20,000 team members aboard with utilizers, I think it's around 15,000 utilizers.
8:28 Speaker 03 On average for maintenance medication. So really exciting. So that patient population being serviced is part of our core features, our savings, just by servicing our team. Those savings allow us to keep the licenses, look at profit models, other parts of retail, meds to beds, things that we can offer at a loss, but for adherence value. So that lets, that opens it up to our other kind of patient populations. So that would be kind of the public. That said, at Morris Town specifically, but definitely Newton as well. Providers lean on us from oncology, from cardiology, from some need-based programs to really help local community members as well as those traveling for, let's say, Morris Town for oncology care. We have a large oncology section there.
9:12 Speaker 03 And we have pharmacy services built in and kind of accelerated contracts, as well as we meet with stakeholders to see if the services we can offer can match the current need. We have patients who might be on hospice, who may not be able to fill a medication. It's all around the board. We treat so many across our locations of retail, you know, within our multi-contracts through LeaderNet via Cardinal, as well as direct contracts with Medicaid, really anywhere we can help out. It's been a very successful. The amount of patients and the categories are dynamic. In this past year, we have the, we serviced the most amount of grant patients,
9:52 Speaker 03 need-based patients and cash patients ever. We also served the largest volume, including all, including our team members. It's been a kind of a multifaceted year of growth for us across both stores in our system with kind of, I wouldn't say everyone relying on us, but our ability to provide features specific to practices, paired with being a patient-facing, public pharmacy, and kind of held together at the base, allowing us to do all these things, is servicing our team members at a financial benefit. So really, it's a multifaceted group of patients. We try to help as many as we can.
10:27 Speaker 02 Well, with so many different types of services that you're offering and all these amazing patients that you serve and all these different things that you have kind of either dipped your toe in or just, you know, went full into the pool of all these different services, what reimbursement challenges has your retail pharmacy faced?
10:44 Speaker 03 So I would say everything you've read in the newspapers and more, just kidding. Reimbursement is, you know, across pharmacy for years, maybe the 90s, maybe after the tipping point of the 90s, reimbursement challenges are across the industry clearly not getting better for independents. It's clearly more challenging, even with the even playing field with the DIR fees of 2024 going away. We saw at those time, a lot of the Part Ds and competitive contracts for patients that we want to reach, patients that are common, those using our services at our health system and maybe being a discharge and maybe non-preferred, or might be we're at the five cent reimbursement, you know, kind of joke of that year across
11:29 Speaker 03 the board. Maybe it's some of the other, not chains, but other PBMs with, as we all know, over time, the contracts aren't degrading. They're calculating to be vertically integrated with, you know, those payers and to have their rebates for the most expensive medications. And their benefit is not to fill it through community as well as we're community, even though we're, you know, we work within Atlantic Health. Our goal is the community and that's also how we're subscribed with Cardinal. So reimbursement challenges are every single day. We have so many features with you guys. I have direct calls from our teams, you know, asking for assistance with claims, asking for help with purchasing. It's a constant
12:10 Speaker 03 thing that really needs management. I actively work on this and this is something that kind of, yeah, was transformed between 2021 and 2022 with us. Part of it was working with your team and the RCS team regarding monitoring some of these functions on the purchasing side, on the claim side, looking at some of these MAC issues, things that are invisible things that hit your pharmacy's bottom line.
12:32 Speaker 02 Well, how did you identify Cardinal Health's reimbursement, the RCS, our reimbursement consulting services solution as a potential solution?
12:42 Speaker 03 In this case, we were super lucky. So when I came onboard, aware of RCS services and similar things from other companies and providers, working across pharmacy for many years, but specifically RCS, when I came onboard in 2021 at Atlantic, we were current subscribers, the services, I would say were a little bit less, or I would say less, they weren't fully being optimized or utilized, and they were also kind of fractured by site, meaning different people would take the calls and then the representative kind of had a different approach. And we kind of, I took the reins in 2021, and we standardized our RCS meetings and a number of other things, including our charging formulas. We reevaluated everything in that calendar year and into 2022, in the fall, we made a number of changes. And one
13:27 Speaker 03 of those is we kind of took the RCS calls and meetings with our representative much more seriously. We actually asked for kind of changes in our reporting. Can we get customized reporting? Hey, we're having issues with specific generics. Can we get those filtered by loss? You know, we're having issues with a particular PBM. I won't name specific ones. You can think of all the big three or four, and just issues with all of them. You know, how do we remain competitive? And it was a combination of really using purchasing interventions, audit education at our sites, real-time reprocessing, which is an RCS tool of kind of identifying claims within a short weird window that you can reprocess it, to really jump in there
14:10 Speaker 03 and make a change before it's permanent, as well as train proactively. So kind of a great combination of those things. So we were lucky to have it, I guess, is the overall question. That said, we really started using it at that time.
14:24 Speaker 02 Yeah, being proactive, I think, is something that pharmacists are learning to get better and better at. You know, it's always, you know, a lot of pharmacists that we've talked to, obviously in the past, have been a little bit reluctant for change and implementing solutions like this. But I feel like when you do it in the right way, and you kind of guide yourself into it, and you could see how much it could help, it really does benefit the pharmacy and the bottom line overall. John, how has enrolling in this solution addressed the specific financial pressures you were experiencing overall?
14:51 Speaker 03 Jason, I would say overall, it really gives us peace of mind. Kind of, it might sound cheesy, I would say power of the team. So internally, we have our teams at Atlantic and Cardinal has multiple services. But when we get together with our representative, who's amazing, we're able to see direct through lines from the actions that we take on purchasing, driven by our meetings with our RCS agent, review the claims and our ability to, how that trickles down to our overall goal of maintaining margin positive. Business overall, obviously, claim to claim, things are all over the place and it's different challenges. But really that, looking at the big picture, knowing that our rep has our back as well as going to present me at every single meeting with something that I'm not expecting, which
15:35 Speaker 03 is great, because it's things we wouldn't have seen normally by not accepting, by not trying the features, basically. Could be a claim, could be a loss, it could be a purchasing opportunity.
15:46 Speaker 02 I actually wanted you to just mention a little bit more about the RCS team, the reimbursement consulting services team, because, you know, it's kind of in the name. It's not just helping people, obviously, helping pharmacies get better reimbursements, but it's really, there's someone on the phone each and every day to help guide you if you have those questions. Talk a little bit more about that and that experience.
16:08 Speaker 03 Absolutely. So the calls we have are direct and dynamic, they're bi-weekly. And what it entails is someone, our expert, who's reviewed our weekly claims for both of our pharmacies, will give us real-time input, kind of on risks, concerns, could be from something simple like day supply, could also be audit risk, FDA package, insert information, could be recommendations for package size. It could also be some internal intel of what to watch out for, that other pharmacies are reporting from either audit behaviors or things that we need to be better prepared for as a team across independent band together, as well as that we need to educate our sites.
16:49 Speaker 03 I work directly with our site teams at MMC and NMC, as well as our team member pharmacy. And a lot of what I learned from our RCS, either the direct intel and/or specific information on claims and processes, are issues that are across all of our stores. I'll often be resharing and kind of making my own education back to our teams. They lean on me as a resource for kind of everything that's processing, in addition to some of the business and quality programs. But I really... Would be without something to back it up with if I had, I would not have a service that provides me what I need to share back to our teams regarding Processing Weekly without that.
17:27 Speaker 02 Yeah, I appreciate you saying all that because I really do want people to understand that is a big part of what the RCS solution does, you know, walking you through these, those certain situations, how to maybe implement them throughout your other pharmacies and really it's not just going in blind and trying to figure it out on your own once your solution is up and running. It's, it's really a partnership that you build over the course of time, especially as soon as you, you know, onboard and you know, to that, to that end, what was the onboarding process like? You know, we talked about some pharmacists getting a little bit, you know, maybe have some trepidation about getting into a new solution, you know, affecting their pharmacy business. But what was the onboarding process like and what was required for your
18:10 Speaker 02 retail pharmacy to begin using RCS?
18:13 Speaker 03 So since we were up and running, you know, prior to my onboard with Atlantic with the RCS services, I believe it's a contractual add-on. I've been told previously, it's a very simple way. So basically, once you're signed up within the, the package, it kind of is attached to your username. But my experience was a friendly representative reached out to me, basically, once the service was active, to set, set some time to kind of see what we could glean from the service. And at first, it was a little uncomfortable for myself and, you know, you hear of services, you're like, what's the value of this? After dedicating some, some time to kind of going through the reports that existed and then honing in on the ones that help us uniquely at Atlantic. So some of our claims under cost rebate and,
18:55 Speaker 03 and those programs for, for losses, things like that, where we need to look for opportunities as well. It was really simple and for me, for us, it was a simple process because it was already up. But I would imagine the experience would be translatable to other pharmacies to not be afraid of. It's super helpful. It's person-based, based on your rep and they'll provide and use the kind of hard details and numbers to help your sites uniquely. And ours vary. We actually use the same tools, but different reports based on, you know, the patients we, and kinds of programs at each site to best use our time.
19:27 Speaker 02 Well, speaking of numbers, because I'm sure that's what mostly pharmacists care about, what financial improvements or opportunities has your retail pharmacy uncovered since implementing RCS? I know you went through a little bit before, but specifically what has RCS done to uncover and help you implement some different solutions in your pharmacy?
19:47 Speaker 03 Sure. So the tools with the active store level decisions, so it's kind of a day to day. What big picture financially has RCS done for Atlantic Health? I would say it arms us, it identifies short-term losses and provides additional protections for verification, high-risk audit items, it prepares us for audits, prevents audits, and those are all quantifiable items. We've seen the most audits ever in this past 2025 at Atlantic. We did very well on all of them, subsequent years as well, with some of the tools in preparation, as well as mitigation and how to prepare and reply to those within FDA indications, always to our benefit. That's a value that would be individually audit-based, but I can tell you there was greater than six in 2025.
20:32 Speaker 03 Definitely in the six figures and beyond, depending on protected dollar value of those. And that's just one quantification. The RCS to our bottom line is essential for us to stave off issues with purchasing. In 2025, we basically, we have 25% more patients, we had greater than 50% increases in revenue. Our margin is net positive. A lot of pharmacies' margins is not net positive. So not to get into the exact numbers, but our ability with this very aggressive TBM kind of environment that has been going on for a while, but is more difficult than ever. The core takeaways for us are remaining net margin. In one year, we more than doubled our internal MMV and our team of pharmacy,
21:16 Speaker 03 and that bolsters our bottom line and the dollars that we're able to redistribute for quality programs. So RCS has been essential to some of those values and our ability to continue.
21:28 Speaker 02 And with that value, have you found that within RCS and what it's doing in your bottom line? Is there, have there been discoveries within that that has made you change your business model? You know, you have a little bit more, let's say, financial flexibility. How has this maybe affected your business model at all?
21:47 Speaker 03 That's a great question, Jason. So I would say it has bolstered kind of our ongoing quality model. So at Atlantic Health, quality is our goal. We offer many health services. We have Atlantic Medical Group. We serve the community across Northern New Jersey and actually part of Central New Jersey now. And our goal is that adherence, that H cap rating, that patient experience, which is not known in the reconciliation of pharmacy outpatient pharmacy. You know, we see dollars, we see cents. What it has allowed us to do is by mitigating audits, by mitigating financial loss, by ensuring net margin positive at our retail units year over year. That allows us to grow with those core features.
22:26 Speaker 03 We've introduced technology meds to bedside readers for point of sale systems at both stores, M C and N M C. And part of that is the support of this model, being able to keep those net margin positive for our retail sides while still having our core feature prescriptions for our team members that are kind of the bedrock of keeping our functionality and our fingerprint or footprint, rather, at our sites.
22:51 Speaker 02 So I gotta say, what advice would you give an independent pharmacist experiencing similar reimbursement challenges? I know, you know, maybe part of me wants you to be like, oh, just sign up for R C S. But I know that's not, you know, the avenue everybody can take. But in your experience, what is the advice you would give an independent pharmacist experiencing these reimbursement challenges? What to look for and, you know, finding the right partner like an R C S to to help, to help improve your financial business?
23:19 Speaker 03 Great. I would say to them, you absolutely in today's environment need Cardinals R C S services with meetings with representative or something identical from another company to get the most out of the, you know, your pre and post processing market assistance intel. Actions in real time that you need to take could be purchasing, could be discharge. I'm thinking right away this year, there's fedaxomycin for our inpatient, there's F D A recommendations, there's P B Ms going against all that. Without consultation with other pharmacies, which independents are great at doing, our R C S agent kind of connecting a lot of these behaviors in the market and ways to go with that. We wouldn't have a leg up and there's other features.
23:59 Speaker 03 I would like to let everyone know, I think they need something like this that provides the ability and insight to act on both pre Post audit risks to allow training and basically identify performance at sites to see purchasing decisions and mistakes coming through on the claim side to go back and make changes to protect your bottom line. I think it's essential. So just wanted to share as a service type essential and a great thing for RCS as well as other other programs like it is that they're compatible with other tools like that communication with other pharmacies, like subscriptions to groups, like also I'd say Relay Health is a product that's very
24:39 Speaker 03 popular almost in all systems. It's not as savvy. It also does catch a lot of errors and it is totally compatible with RCS. So I think the more the merrier. Look at your costs, you know, but service like RCS for us is essential. And I can only imagine, you know, our ability to continue providing services and expand and reinvest in our patients. The volatile arm of retail is essential and we're keeping, we've been keeping it net positive. This is one feature that really adds to that allows us to.
25:11 Speaker 02 Well, John, last question for you. And I just, I always like to ask pharmacists. I know, you know, you guys deal with so many different patients and you've connected a lot of different patients. There's probably a lot of patient stories out there. Can you think of a, of a recent patient story or a group of patients that not only RCS helped you, help you treat, but also gave you the flexibility to maybe expand a different service so you could help that patient?
25:37 Speaker 03 Sure, I can think of a kind of an immediate thing. It's probably not a gold horse driveway story, but it's a real time one that's been going on. We've been watching it this year. It's not exciting outside of pharmacy, but it really does connect to our patients. Both our Newton and Morris Stone stores, deficit for discharge patients with C diff, you know, transitions to the community. That's not always the right medication for it. However, when it is, we don't diverge from that. So in the market, we've seen with the launch of the generic, it's a sourced product currently, which is great that Cardinals participating in that. But what we've seen, like all drugs, when they go generic is kind of a fracturing of payers and risks. And we've had to have really
26:17 Speaker 03 Intense communications to ensure we're continuing service while monitoring that reimbursement situation. And it's one of those things where they'll tell you it's sure to get better, but at launch, you have multiple net losses on said product, you know, following interchange laws, trying to help patients. Like at our facilities, we'll see patients who will maybe have four days of inpatient intensive therapy. The treatment plan is to bridge them. They're on a 10 day bedaxomycin deficit regimen, let's say. And they'll get their discharge medications. The PBMs last year started going after breaking of packages for that for medication. And that only got confounded with all of a sudden the generics out, pharmacies are giving the generic, patients are thinking they're saving. And then pharmacies are losing thousands often for claim.
27:02 Speaker 03 So we've been really working with our RCS agent. She's been amazing. The market conditions, Cardinal can't change those things, but we're seeing on the week to week where it's getting better. We're also, we're able to negotiate a store level special pricing and lock it in for our stores because of our population value. And as well as that protects us on the backend, we're prepared for audits on any and all of those for the medical benefit of the patient. Now we're, we're following the FDA indication to continue those therapies for that 10 days, unless there's some reason to stop it. We have follow-up teams from our, the medical side that track adherence. It's really cool to be part of that. And it's one of those things where we're not making money on that particular product,
27:43 Speaker 03 but it's essential for us to help our community. So we're actively doing everything we can. Our RCS tools and agent really helps us with those, helps us better monitor those. And we'll roll with the punches. Our net effect is we don't want that patient to get rehospitalized. And there's not one that same story is, I think it was just eight yesterday, eight in the past quarter across two our stores. So it's eight unique patients that we, we would, we want them to be taken care of.
28:09 Speaker 02 No, yeah, I love that. Yeah, I love that. That's incredible. And thank you so much for what you and your team do. I want to say thanks to Jean-Paul again for giving our listeners some great insights on improving your pharmacy's financial health, utilizing Cardinal Health reimbursement consulting services. Thanks for listening to today's episode of the. Cardinal Health Counter Talk Podcast and as a reminder, if this is your first time listening, make sure you subscribe and download the Cardinal Health Counter Talk Podcast wherever you get your podcasts. See you on the next episode and take care everyone.
28:59 Speaker 02 You
Previous Empowered Motherhood and the Fight for Maternal Health Equity with Dr. Eboni January | MaternalRx Next The Blueprint to Pharmacy Success in 2026 | Pharmacy Tech Trends: PrimeRx Page updated November 14, 2026 · transcript and summary are machine-generated